- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06977100
- Original Trial
Journaling Intervention for Temporomandibular Disorder (TMD) and Chronic Overlapping Pain
Examining the Feasibility and Acceptability of a Journaling Intervention in Alleviating Temporomandibular Pain
The goal of this clinical trial is to learn whether a 2-week gratitude journaling activity is feasible and acceptable for individuals with Temporomandibular Disorder (TMD) and chronic overlapping pain. The study will also look at whether this activity is helpful in reducing pain and how much it interferes with daily life.
The primary aims of this study are to:
- Assess whether individuals with TMD and chronic overlapping pain are able to complete the 2-week gratitude journaling activity as planned (feasibility).
- Evaluate how acceptable participants find the gratitude journaling activity (acceptability).
The secondary aim of this study is to:
• Explore whether the gratitude journaling activity reduces pain and its impact on daily life, compared to a general wellness journaling activity.
Participants will:
- Attend two in-person visits to complete questionnaires and take part in tests that measure how sensitive they are to pressure and heat.
- Complete a 2-week journaling activity at home, writing in their journal on three days of their choice per week.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Melissa Makhoul, Phd, MSN, RN
- Phone Number: 352-246-3153
- Email: melissamakhoul@ufl.edu
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32610
- Recruiting
- University of Florida
-
Contact:
- Melissa Makhoul, Phd, MSN, RN
- Phone Number: 352-246-3153
- Email: melissamakhoul@ufl.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- participants between the ages of 18 and 80
- pain in the temporomandibular (TMD) region (jaw and/or temple area)
- duration of pain is at least 3 months
- average pain score ≥4 on a 0-10 numerical rating scale over the past week
- have at least one additional chronic overlapping pain condition (COPC) including fibromyalgia, irritable bowel syndrome, migraine-type headache, tension-type headache, low back pain, interstitial cystitis/painful bladder syndrome or chronic prostatitis, myalgic encephalomyelitis/chronic fatigue syndrome, vulvodynia, and painful endometriosis.
- able to read, understand, and write in English.
Exclusion Criteria:
- history of TMD surgery
- neoplasm or injury/trauma to the TMD area
- cancer-related pain
- scheduled for any surgeries during the study time-frame
- current participation in another clinical trial or psychological treatment for any pain-related condition that would interfere with study outcomes
- pregnant or lactating
- severe motor impairments (e.g., muscular dystrophy)
- severe psychiatric conditions (e.g., uncontrolled mood disorders)
- severe neurological or cognitive impairments (e.g., uncontrolled Parkinson's disease)
- any other conditions that in the opinion of study investigators could make participation in the study unsafe
- use of opioids within 48 hours prior to laboratory visit
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Gratitude Intervention
|
Participants in this group will receive a gratitude journal where they will be asked to write down three things they are grateful for each day and reflect why they are grateful for these things.
Journaling will take place from the comfort of their home on three days of their choice per week, for a total duration of two weeks.
|
|
Active Comparator: General Wellness
|
Participants in this group will receive a general wellness journal where they will be asked to reflect on three things that happened, or they did during the day (daily activities).
Journaling will take place from the comfort of their home on three days of their choice per week, for a total duration of two weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant Retention
Time Frame: Baseline to Week 4
|
Percentage of participants who initiate treatment/intervention and complete the post-intervention assessment at the 4-week time-point.
|
Baseline to Week 4
|
|
Treatment Satisfaction
Time Frame: Week 4
|
Single-item Treatment Satisfaction Questionnaire: Response to self-reported item assessing overall satisfaction with the treatment.
The item is rated on a 1 to 4 scale (1 = Quite Dissatisfied to 4 = Very Satisfied) with the mean value calculated.
A higher score indicates greater satisfaction with the treatment.
|
Week 4
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain Intensity
Time Frame: Baseline, Week 4
|
The PROMIS-Pain Intensity short form is a 3-item measure assessing pain intensity over the past 7 days (i.e., "how intense was your pain at its worst"), as well as current level of pain.
The total score for the PROMIS Pain Intensity short form will be calculated by summing the numerical values of the responses to each of the three items.
After obtaining the total raw score, it will then be converted into a T-score, which standardizes the score with a mean of 50 and a standard deviation of 10, based on the general U.S. population.
|
Baseline, Week 4
|
|
Pain Interference
Time Frame: Baseline, Week 4
|
The PROMIS-Pain Interference short form is an 8-item measure assessing the extent to which pain interferes with physical, mental, cognitive, emotional, recreational and social activities over the past 7 days (i.e., "how much did pain interfere with work around home").
The total score for the PROMIS-Pain Interference short form will be calculated by summing the numerical values of the responses to each of the eight items.
After obtaining the total raw score, it will then be converted into a T-score, which standardizes the score with a mean of 50 and a standard deviation of 10, based on the general U.S. population.
|
Baseline, Week 4
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB202500344
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Temporomandibular Disorders (TMD)
-
McGill University Health Centre/Research Institute...Not yet recruitingTemporomandibular Joint | Temporomandibular Dysfunction (TMD) | Temporomandibular Joint and Muscle Disorder | Temporo-mandibular Dysfunction | Temporomandibular Disorder (TMD) | Temporomandibular Disorders (TMDs)Canada
-
Fundación Universidad Católica de Valencia San...RecruitingTemporomandibular Disorders (TMD) | Temporomandibular Dysfunction (TMD) | Temporomandibular Disorder (TMD) | Chronic Orofacial PainSpain
-
Mansoura UniversityActive, not recruitingTMD | TMD/Orofacial Pain | Temporomandibular Disorder (TMD)Egypt
-
Semmelweis UniversityBajcsy-Zsilinszky HospitalRecruitingOrofacial Pain | Temporomandibular Disorders (TMD) | Temporomandibular Joint and Muscle Disorder | TMD/Orofacial Pain | Temporo-mandibular Dysfunction | Temporomandibular Disorder (TMD) | Temporomandibular Disorders (TMDs)Hungary
-
Istanbul UniversityThe Scientific and Technological Research Council of TurkeyCompletedTemporomandibular Disorders (TMD) | Temporomandibular PainTurkey (Türkiye)
-
Tel-Aviv Sourasky Medical CenterEnrolling by invitationTemporomandibular Disorders (TMD) | Temporomandibular Dysfunction (TMD) | Temporomandibular Joint and Muscle DisorderIsrael
-
Minia UniversityNot yet recruitingTMD | Temporomandibular Disorders (TMD)
-
B.P. Koirala Institute of Health SciencesCompletedTemporomandibular Joint Disorder | Temporomandibular Disorders (TMD)Nepal
-
Centre Hospitalier Universitaire de NiceNot yet recruiting
-
Lund University HospitalLund UniversityRecruitingTemporomandibular Disorders (TMD) | Temporomandibular Joint AnkylosisSweden
Clinical Trials on Gratitude
-
University of SheffieldThe Leeds Teaching Hospitals NHS Trust; Sheffield Teaching Hospitals NHS Foundation... and other collaboratorsCompletedDepression | Wellbeing | Psychological Distress | Happiness | Emotional Distress | AffectUnited Kingdom
-
Centre Hospitalier Universitaire VaudoisCompletedPalliative CareSwitzerland
-
University of California, Los AngelesCompletedGratitude + No Expectations | Gratitude + Expectations | Events ControlUnited States
-
Philipps University Marburg Medical CenterCompletedDepression Moderate | Depression MildGermany
-
University of FloridaNational Institute on Aging (NIA)CompletedExercise | Breast Neoplasm Female | Feasibility Studies | Cardiometabolic Syndrome | Cancer Survivors | African Americans | Women | Psychology, PositiveUnited States
-
Centre hospitalier de l'Université de Montréal...Unknown
-
University of MalayaCompletedStress, PsychologicalPakistan
-
Philipps University Marburg Medical CenterCompleted